At present, the main problems in the treatment of inflammatory bowel disease in China are: 1, the classification of the disease is not clear, the patient belongs to which type, whether it is in the active stage, the doctor does not understand this thoroughly, which directly leads to excessive or insufficient treatment plan. 2, drug treatment indications, principles are not clear, there are inappropriate use of drugs for the treatment of inflammatory bowel disease; for example, I have seen many patients with Crohn’s disease rely on hormone maintenance therapy for a long time, rather than choose immunosuppressive drugs, guidelines and literature written very clearly, glucocorticoids can only induce remission, but can not be used as maintenance therapy, many patients and even doctors there is a lack of understanding of immunosuppressive drugs Even inexplicable fear, only see the side effects of immunosuppressants, but not its effective role. 3.Insufficient attention to nutritional support therapy, many patients with relatively severe disease do not receive guidance and timely nutritional intervention from doctors or dietitians, and eat at will, further aggravating the changes in their condition. 4.The timing of surgical intervention is not clear, there is too early and too late, and the surgical method is too small and too large. 5. Insufficient health education, and many patients have the situation of self-adjustment or even discontinuation of medication after discharge. How to gradually promote the individual standardized treatment of inflammatory bowel disease, this treatment is not set in stone, not to move the book hard to apply the guidelines, is in full combination with the patient’s condition, according to the existing diagnosis and treatment guidelines, to give patients the most suitable treatment.